Wells Fargo & Company upgraded shares of Marsh & McLennan Companies (NYSE:MRSH – Free Report) from an equal weight rating to an overweight rating in a report issued on Thursday morning, MarketBeat Ratings reports. They currently have $235.00 target price on the financial services provider’s stock, up from their previous target price of $197.00.
A number of other brokerages have also recently weighed in on MRSH. The Goldman Sachs Group dropped their price target on shares of Marsh & McLennan Companies from $197.00 to $191.00 and set a “neutral” rating for the company in a research report on Thursday, October 1st. Mizuho increased their price objective on shares of Marsh & McLennan Companies from $200.00 to $218.00 and gave the stock a “neutral” rating in a research report on Friday, November 13th. BMO Capital Markets raised Marsh & McLennan Companies from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $204.00 to $230.00 in a research report on Tuesday, November 3rd. Keefe, Bruyette & Woods upped their price target on Marsh & McLennan Companies from $186.00 to $201.00 and gave the stock a “market perform” rating in a research note on Monday, October 19th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Marsh & McLennan Companies in a research note on Wednesday, November 4th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies has an average rating of “Moderate Buy” and an average price target of $210.63.
Read Our Latest Stock Analysis on MRSH
Marsh & McLennan Companies Stock Up 0.8%
MRSH stock opened at $206.22 on Thursday. The stock’s fifty day simple moving average is $188.18. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market capitalization of $98.06 billion, a PE ratio of 24.67, a price-to-earnings-growth ratio of 2.79 and a beta of 0.53. Marsh & McLennan Companies has a 52-week low of $156.60 and a 52-week high of $214.00.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings results on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, beating the consensus estimate of $1.96 by $0.07. The business had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The firm’s revenue was up 8.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Marsh & McLennan Companies will post 10.49 EPS for the current year.
Marsh & McLennan Companies Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Thursday, October 1st were paid a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Thursday, October 1st. Marsh & McLennan Companies’s payout ratio is presently 47.37%.
Insider Activity
In other news, CEO Dean Klisura sold 4,194 shares of Marsh & McLennan Companies stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $838,800.00. Following the completion of the transaction, the chief executive officer owned 20,935 shares in the company, valued at approximately $4,187,000. This trade represents a 16.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Stacy Mills sold 1,215 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $200.00, for a total value of $243,000.00. Following the transaction, the vice president directly owned 2,705 shares of the company’s stock, valued at approximately $541,000. This represents a 30.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.38% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Marsh & McLennan Companies
Large investors have recently bought and sold shares of the business. Stonebrook Private Inc. raised its holdings in Marsh & McLennan Companies by 70.7% during the third quarter. Stonebrook Private Inc. now owns 2,099 shares of the financial services provider’s stock worth $358,000 after purchasing an additional 869 shares in the last quarter. PCM Encore LLC boosted its holdings in shares of Marsh & McLennan Companies by 2.2% in the 3rd quarter. PCM Encore LLC now owns 3,456 shares of the financial services provider’s stock valued at $590,000 after buying an additional 73 shares in the last quarter. Defiance ETFs LLC grew its position in shares of Marsh & McLennan Companies by 12.4% in the 3rd quarter. Defiance ETFs LLC now owns 2,201 shares of the financial services provider’s stock valued at $374,000 after buying an additional 242 shares during the last quarter. Kestra Advisory Services LLC grew its position in shares of Marsh & McLennan Companies by 11.5% in the 3rd quarter. Kestra Advisory Services LLC now owns 15,722 shares of the financial services provider’s stock valued at $2,684,000 after buying an additional 1,616 shares during the last quarter. Finally, Advisors Asset Management Inc. acquired a new stake in Marsh & McLennan Companies during the 3rd quarter worth $4,694,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Key Marsh & McLennan Companies News
Investors following MRSH have been watching these news items:
- Positive Sentiment: Marsh’s Oliver Wyman is acquiring Synpulse, a financial-services and technology consultancy. The deal would add AI engineering and technology capabilities, potentially strengthening Oliver Wyman’s consulting offer and growth prospects in financial services. Zacks article on Synpulse acquisition
- Positive Sentiment: A separate valuation article argues MRSH could trade below fair value, offering a potentially supportive view of the stock, although the supplied headline gives no valuation assumptions. Valuation article
- Neutral Sentiment: Marsh’s prominent presence at the Las Vegas Grand Prix as Formula 1’s official risk and insurance-brokering partner may support brand visibility, but no direct financial effect was disclosed. Marsh Formula 1 announcement
About Marsh & McLennan Companies
Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges. The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
